BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20646743)

  • 1. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma.
    Abouassaly R; Alibhai SM; Shah N; Timilshina N; Fleshner N; Finelli A
    Urology; 2010 Oct; 76(4):895-901. PubMed ID: 20646743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Patterns, Outcomes, and Costs Associated With Localized Upper Tract Urothelial Carcinoma.
    Fero KE; Shan Y; Lec PM; Sharma V; Srinivasan A; Movva G; Baillargeon J; Chamie K; Williams SB
    JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34805743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative and Survival Outcomes After Cytoreductive Surgery in the Treatment of Metastatic Upper Tract Urothelial Carcinoma.
    Pollock G; Hsu CH; Batai K; Lee BR; Chipollini J
    Urology; 2021 Jul; 153():244-249. PubMed ID: 33482133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.
    Lughezzani G; Burger M; Margulis V; Matin SF; Novara G; Roupret M; Shariat SF; Wood CG; Zigeuner R
    Eur Urol; 2012 Jul; 62(1):100-14. PubMed ID: 22381168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies.
    Giulioni C; Brocca C; Tramanzoli P; Stramucci S; Mantovan M; Perpepaj L; Cicconofri A; Gauhar V; Merseburger AS; Galosi AB; Castellani D
    World J Urol; 2024 May; 42(1):318. PubMed ID: 38743260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the initial clinical presentation of upper tract urothelial carcinoma on histopathological tumor features.
    Jakus D; Šolić I; Borovac JA; Šitum M
    Int Urol Nephrol; 2024 Apr; 56(4):1335-1341. PubMed ID: 38015383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic oxidative stress indices predicts prognosis in patients with urothelial carcinoma of the upper urinary tract after radical nephroureterectomy.
    Liu J; Lai S; Wu P; Wang J; Wang J; Wang J; Zhang Y
    Eur J Med Res; 2023 Oct; 28(1):469. PubMed ID: 37898799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association between Lymph Node Dissection and Survival in Lymph Node-Negative Upper Urinary Tract Urothelial Cancer.
    Ślusarczyk A; Zapała P; Piecha T; Rajwa P; Moschini M; Radziszewski P
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma.
    Kobayashi G; Hayashi T; Sentani K; Uraoka N; Fukui T; Kido A; Katsuya N; Ishikawa A; Babasaki T; Sekino Y; Nose H; Arihiro K; Hinata N; Oue N
    Diagn Pathol; 2023 Sep; 18(1):106. PubMed ID: 37737200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for extraurothelial recurrence in upper tract urothelial carcinoma after radical nephroureterectomy: a retrospective study based on a Chinese population.
    Luo Z; Jiao B; Yan Y; Su C; Pan Y; Zhao H; Bo Y; Zhang G; Ding Z
    Front Oncol; 2023; 13():1164464. PubMed ID: 37621681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative adjuvant radiotherapy for patients with upper tract urothelial carcinoma (UTUC) who underwent kidney-sparing surgery (KSS): a single-center study.
    Guan H; Wang G; Wang W; Zhou Y; Liu Z; Hou X; Yan J; Sun S; Hu K; Zhao J
    Radiat Oncol; 2023 Jul; 18(1):120. PubMed ID: 37464353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metachronous urothelial carcinoma in the renal pelvis, bladder, and urethra: A case report.
    Zhang JQ; Duan Y; Wang K; Zhang XL; Jiang KH
    World J Clin Cases; 2023 May; 11(13):3062-3069. PubMed ID: 37215428
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zimpfer A; Kdimati S; Mosig M; Rudolf H; Zettl H; Erbersdobler A; Hakenberg OW; Maruschke M; Schneider B
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of secondary bladder cancer following radical nephroureterectomy for upper tract urothelial carcinoma: characteristics, risk factors, and predictive value.
    Lai S; Wu P; Liu S; Seery S; Liu J; He L; Liu M; Zhang Y; Wang JY; Xu T
    BMC Urol; 2022 Dec; 22(1):211. PubMed ID: 36566200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy.
    Hsieh HC; Wang CL; Chen CS; Yang CK; Li JR; Wang SS; Cheng CL; Lin CY; Chiu KY
    PLoS One; 2022; 17(12):e0278038. PubMed ID: 36454803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival Impact of Nephroureterectomy for De Novo Stage IV Nonmetastatic and Metastatic Upper Tract Urothelial Carcinoma.
    Lin WY; Lin MH; Yang YH; Chen WC; Huang CE; Chen MF; Wu CT
    Front Surg; 2022; 9():903123. PubMed ID: 35693310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration Group.
    Lin CY; Weng HY; Tai TY; Wu HC; Chen WC; Chen CH; Huang CY; Lo CW; Yu CC; Tsai CY; Wu WC; Jiang YH; Lee YK; Hsueh TY; Chiu AW; Chiang BJ; Huang HC; Chen IA; Chen YT; Lin WY; Wu CC; Tsai YC; Lee HY; Li WM
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinoma.
    Kobayashi G; Hayashi T; Sentani K; Babasaki T; Sekino Y; Inoue S; Uraoka N; Hanamoto M; Nose H; Teishima J; Oue N; Matsubara A; Sasaki N; Yasui W
    Virchows Arch; 2022 Mar; 480(3):621-633. PubMed ID: 34842980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lymph node dissection at the time of open or minimally invasive nephroureterectomy.
    McIntosh AG; Umbreit EC; Wood CG; Matin SF; Karam JA
    Transl Androl Urol; 2021 May; 10(5):2233-2245. PubMed ID: 34159106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rising incidence rates and unaltered survival rates for primary upper urinary tract urothelial carcinoma: a Dutch population-based study from 1993 to 2017.
    van Doeveren T; van der Mark M; van Leeuwen PJ; Boormans JL; Aben KKH
    BJU Int; 2021 Sep; 128(3):343-351. PubMed ID: 33690922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.